CORONA / NSE / Biotechnology & Drugs
Corona Remedies
1Y Price Trend
Key Information
Recommendations
Target High1,951.3
Target Low1,336.95
Target Mean0
Target Median0
Risk Metrics
Overall RiskBalanced risk
Board Risk35.38
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
CORONA Remedies promoter confirms no encumbrance on shares in FY26 scanx.trade
Corona Remedies Ltd Technical Momentum Shifts Amid Mixed Market Signals Markets Mojo
Corona Remedies to hold investor meetings in Singapore on June 8 scanx.trade
Corona Remedies Ltd Downgraded to Sell Amid Technical and Financial Concerns Markets Mojo
Corona Remedies Ltd is Rated Hold Markets Mojo
CORONA Remedies receives EU-GMP certification for hormone facility Indian Pharma Post
CORONA Remedies secures EU-GMP certification for hormone facility, renews approval for Ahmedabad OSD plant Express Pharma
Corona Remedies Ltd Technical Momentum Shifts to Mildly Bullish Amid Hold Rating Upgrade Markets Mojo
© SharekeyX | Rusaka Technologies 2024-2026

